NPR: Why A Vaccine That Works Only A Third Of The Time Is Still A Good Deal
“…[T]he expectation among researchers is that, even if RTS,S is rolled out on a large scale, the other current measures against malaria — notably bed nets and mosquito control programs — will have to continue to be used if significant progress is going to be made against this tropical disease. And even if it isn’t the holy grail, the vaccine is making history by spurring immunity against a parasite…” (Beaubien, 7/24).